The release of these biomarkers can also be detected in other conditions not necessarily connected to ischemic injuries; biomarkers like neuron-specific enolase (NSE) and S100B can be elevated in infections and sepsis [10,11], and their increase can also be related to tumors [4,12]. This evidence concerns the gene ENO2 and infection.